Skip to main content
Premium Trial:

Request an Annual Quote

Michigan Biomarker Alliance Joins C-Path Institute's Predictive Safety Testing Consortium

NEW YORK (GenomeWeb News) – ClinXus, a non-profit biomarker alliance based in Grand Rapids, Mich., has joined the Critical Path Institute’s Predictive Safety Testing Consortium, ClinXus said today.
 
ClinXus was formed in 2006 using $1.5 million from the Michigan 21st Century Jobs Fund and from in-kind donations from its members, which include the Van Andel Institute, Spectrum Health, Saint Mary’s Health Care, Jasper Clinical Research & Development, Grand Valley State University, and Grand Valley Medical Specialists.
 
ClinXus was formed with the goal of “introducing molecular biomarkers into the clinical trial process,” and “uses the expertise and services of each member institution to provide a single point of contact for clinical research clients, as well as patients and physicians that participate in clinical studies.”
 
The Critical Path Institute was formed in 2005 to support the US Food and Drug Administration’s Critical Path Initiative via collaborative research programs. Its Predictive Safety Testing Consortium is a collection of pharmaceutical companies that have agreed to share and validate each other’s safety testing methods.
 
ClinXus said it is the first non-profit entity to join the PSTC.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.